Skip to Content

Canelo Alvarez Withdraws From His Rematch With Gennady Golovkin

Canelo Alvarez Withdraws From His Rematch With Gennady Golovkin

Canelo Alvarez is under a temporary suspension by the Nevada commission following a pair of failed drug tests in February for a steroid called clenbuterol, and director Bob Bennett has filed a formal complaint against him for doping violations. In the midst of that Alvarez has officially withdrawn from his scheduled, May 5 middleweight championship rematch against Gennady Golovkin in Las Vegas.

A Nevada State Athletic Commission (NSAC) disciplinary hearing is scheduled for April 18, where Canelo Alvarez could face as low as a one-year suspension if commission rule against him. If he cooperates, it reduces the suspension to six months.

News broke on (Tues., April 3, 2018) that the match has been off a table when Eric Gomez, CEO of Alvarez’ promotion company Golden Boy Productions, confirmed the news during a media conference:

“I have always been a clean fighter and I always will be a clean fighter,” Alvarez said during today’s press conference. “I want to prove without a doubt that I have never intentionally ingested Clenbuterol. I have nothing to hide and I want to be open and transparent through this process.”

Alvarez blamed the positive tests were from eating contaminated meat when he was in Mexico.

Alvarez and GGG fought This rematch with unified middleweight champion Gennady Golovkin, whom he fought to a controversial draw last September.

The first contest between Alvarez and Golovkin ended in a controversial draw back in September. “GGG” remain on the card against an opponent to be announced.

For more MMA News, Rumors and Updates follow the Red Monster on Facebook, Twitter, YouTube and Instagram
Max Holloway and Khabib Nurmagomedov poster
Pic: The perfect UFC 223 poster with Max Holloway and Khabib Nurmagomedov is already out
← Read Last Post
Eddie Bravo speaks
Video: Eddie Bravo and Joe Rogan talk the moment they were texted about Tony Ferguson’s injury
Read Next Post →